The FDA approved cisplatin (Platinol) for use in combination with other drugs in the treatment of metastatic testicular and metastatic ovarian cancer
In 1978, the U.S. Food and Drug Administration (FDA) approved cisplatin (Platinol) for use in combination with other drugs in the treatment of metastatic testicular and metastatic ovarian cancer.
Tags:
Source: National Cancer Institute
Credit:
